InsiderClue
Stocks · Health care · Wholesale-Drugs, Proprietaries & Druggists' Sundries

DataMeds AI, Inc.

MEDS Clue Score38
United States Fiscal year ends December CIK 0002030763
$2.96 -12.94% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.96 +318.32% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 21 Feb 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2023Operating income−2.9Net income−2.9EPS, diluted−0.06Fiscal year 2024Revenue18.1Operating income−6.1Net income−6.9EPS, diluted−0.15Fiscal year 2025Revenue23.3 +28.7%Operating income−93.7Net income−101.3EPS, diluted−1.43
FY2023FY2024FY2025
Revenue n/a 18.1 23.3
Growth +28.7%
Operating income −2.9 −6.1 −93.7
Net income −2.9 −6.9 −101.3
Growth
EPS, diluted −0.06 −0.15 −1.43

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2023Fiscal year 2024Gross margin9.7%Operating margin−33.9%Net margin−37.8%Fiscal year 2025Gross margin−27.5%Operating margin−401.7%Net margin−433.9%
FY2023FY2024FY2025
Gross margin n/a 9.7% −27.5%
Operating margin n/a −33.9% −401.7%
Net margin n/a −37.8% −433.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2023Operating cash flow−0.3Fiscal year 2024Operating cash flow−1.2Fiscal year 2025Operating cash flow−10.9
FY2023FY2024FY2025
Operating cash flow −0.3 −1.2 −10.9

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2023Cash0.0Total debt0.4Net cash (debt)−0.3Shareholders’ equity−2.9Fiscal year 2024Cash1.0Total debt22.9Net cash (debt)−21.9Shareholders’ equity6.7Debt to equity3.40Fiscal year 2025Cash0.0Total debt12.6Net cash (debt)−12.6Shareholders’ equity−12.4
FY2023FY2024FY2025
Cash 0.0 1.0 0.0
Total debt 0.4 22.9 12.6
Net cash (debt) −0.3 −21.9 −12.6
Shareholders’ equity −2.9 6.7 −12.4
Debt to equity n/a 3.40 n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−0.3 −1.2 −10.9
Growth
Investment
n/a 0.5 −0.9
Financing
0.4 1.8 10.8

Capital expenditure, dividends and buybacks are shown as money out, so negative.